Helen Ling Selected Research

Helen Ling Research Topics

Disease

14	Parkinson Disease (Parkinson's Disease) 01/2021 - 02/2010
8	Parkinsonian Disorders (Parkinsonism) 01/2021 - 09/2009
7	Multiple System Atrophy 01/2021 - 05/2013
5	Dyskinesias (Dyskinesia) 01/2018 - 06/2011
4	Cognitive Dysfunction 01/2020 - 06/2014
4	Dementia (Dementias) 12/2019 - 01/2014
3	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 08/2015
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 04/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019 - 01/2018
3	Synucleinopathies 12/2019 - 01/2016
3	Tauopathies 01/2018 - 09/2012
2	Hallucinations (Hallucination) 01/2021 - 08/2015
2	Urinary Incontinence 01/2021 - 01/2019
2	Tremor (Tremors) 01/2019 - 02/2010
2	Dystonia (Limb Dystonia) 01/2019 - 01/2018
2	Hypokinesia (Bradykinesia) 01/2016 - 04/2012
2	Frontotemporal Dementia (Semantic Dementia) 08/2015 - 09/2012
1	Corticobasal Degeneration 11/2019
1	Lewy Body Disease (Lewy Body Dementia) 01/2019
1	Dysarthria (Spastic Dysarthria) 01/2019
1	Deglutition Disorders (Dysphagia) 01/2019
1	Camptocormia 01/2019
1	Dysphonia (Spastic Dysphonia) 01/2019
1	Snoring 01/2019
1	Contracture 01/2019
1	Myoclonus (Nocturnal Myoclonus) 01/2018
1	Sleep Apnea Syndromes (Sleep Apnea) 10/2016
1	Parasomnias (Parasomnia) 10/2016
1	Respiratory Sounds (Crackle) 10/2016
1	Neuroacanthocytosis 06/2015
1	Alzheimer Disease (Alzheimer's Disease) 05/2014
1	Down Syndrome (Down's Syndrome) 01/2014
1	Disease Progression 01/2013
1	Dopa-responsive Dystonia 04/2011
1	Tardive Dyskinesia 01/2011
1	Dystonic Disorders (Writer's Cramp) 01/2011
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2011
1	Movement Disorders (Movement Disorder) 01/2011
1	Essential Tremor (Essential Tremors) 01/2011

Drug/Important Bio-Agent (IBA)

11	Levodopa (L Dopa)FDA LinkGeneric 01/2021 - 06/2011
9	SynucleinsIBA 01/2020 - 05/2013
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2016
2	tau Proteins (tau Protein)IBA 11/2019 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2014
2	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 02/2010
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2015 - 02/2010
1	Coloring Agents (Dyes)IBA 12/2019
1	AntibodiesIBA 10/2016
1	alpha-SynucleinIBA 01/2016
1	Amyloid beta-PeptidesIBA 01/2016
1	Apomorphine FDA Link 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2016
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 06/2015
1	Serotonin (5 Hydroxytryptamine)IBA 05/2015
1	Glucose (Dextrose)FDA LinkGeneric 05/2014
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2014
1	Monoamine Oxidase (MAO)IBA 01/2014
1	ImmunosorbentsIBA 01/2014
1	Estriol (Epiestriol)IBA 01/2014
1	EnzymesIBA 01/2014
1	UbiquitinIBA 12/2013
1	Phosphotransferases (Kinase)IBA 12/2013
1	Leucine (L-Leucine)FDA Link 12/2013
1	14-3-3 Proteins (14-3-3 Protein)IBA 01/2013
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2012
1	Guanosine Triphosphate (GTP)IBA 04/2011
1	CopperIBA 01/2011
1	Ceruloplasmin (Ferroxidase)IBA 01/2011
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2011
1	IronIBA 01/2011
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2009

Therapy/Procedure

2	Urinary Catheters 01/2021 - 01/2019
1	Therapeutics 01/2016
1	Denervation 02/2010
1	Kidney Transplantation 09/2009